Global biopharmaceutical leader focused on discovering, developing, and delivering innovative medicines for patients with serious diseases, advancing science in oncology, immunology, and other therapeutic areas.
Notice Date
May 2, 2025
—
July 1, 2025
February 28, 2026
Permanent
No
Libertyville
Illinois
Lake
Northeast 4
